Isda’s Korean OTC law criticism February 17, 2010 X LinkedIn Email Show more sharing options Copy Link URLCopied! Print X LinkedIn Email South Korea’s New Product Approval bill passed its first stage on February 16. The bill has been strongly opposed by Isda. Here are its concerns in full Unlock this content. The content you are trying to view is exclusive to our subscribers. To unlock this content: Take a Free Trial or Login